Page 74 - எங்களுக்கு சர்வதேச வளர்ச்சி நிதி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share Hyderabad: The US International Development Finance Corporation (DFC), America’s development bank, will work with the Hyderabad-based Biological E and finance its increased capacity to further the company’s endeavour to produce 1 billion doses of Covid-19 vaccine by the end of 2022. Though DFC did not specify how much money it will invest in Biological E, it stated that it will invest between $5 million to $500 million per eligible project from the private sector to support the manufacture of vaccines. “It is hard to conceive of an investment with a greater developmental impact than using our financial tools to increase the capacity of vaccine manufacturing to help developing countries in Asia and around the world respond to Covid-19 and other diseases,” DFC’s Chief Operating Officer (COO) David Marchick said.

United statesAndhra pradeshDavid marchickUs international development finance corporationWorld health organizationX women initiativeDevelopment finance corporationOperating officerStringent regulatory authorizationEmergency use listingஒன்றுபட்டது மாநிலங்களில்ஆந்திரா பிரதேஷ்எங்களுக்கு சர்வதேச வளர்ச்சி நிதி நிறுவனம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்எக்ஸ் பெண்கள் முயற்சிவளர்ச்சி நிதி நிறுவனம்